Correlation Between Aerovate Therapeutics and Seer
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Seer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Seer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Seer Inc, you can compare the effects of market volatilities on Aerovate Therapeutics and Seer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Seer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Seer.
Diversification Opportunities for Aerovate Therapeutics and Seer
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Aerovate and Seer is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Seer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seer Inc and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Seer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seer Inc has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Seer go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Seer
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.16 times less return on investment than Seer. But when comparing it to its historical volatility, Aerovate Therapeutics is 1.15 times less risky than Seer. It trades about 0.04 of its potential returns per unit of risk. Seer Inc is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 231.00 in Seer Inc on September 18, 2024 and sell it today you would earn a total of 3.00 from holding Seer Inc or generate 1.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Aerovate Therapeutics vs. Seer Inc
Performance |
Timeline |
Aerovate Therapeutics |
Seer Inc |
Aerovate Therapeutics and Seer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and Seer
The main advantage of trading using opposite Aerovate Therapeutics and Seer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Seer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seer will offset losses from the drop in Seer's long position.The idea behind Aerovate Therapeutics and Seer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Seer vs. Oric Pharmaceuticals | Seer vs. Anebulo Pharmaceuticals | Seer vs. Cullinan Oncology LLC | Seer vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |